PT  - JOURNAL ARTICLE
AU  - Kufe, Clement N.
AU  - Goedecke, Julia H.
AU  - Masemola, Maphoko
AU  - Chikowore, Tinashe
AU  - Soboyisi, Melikhaya
AU  - Smith, Antonia
AU  - Westgate, Kate
AU  - Brage, Soren
AU  - Micklesfield, Lisa K.
TI  - Physical behaviours and their association with type 2 diabetes risk in urban South African middle-aged adults: An isotemporal substitution approach
AID  - 10.1101/2022.02.08.22270616
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.02.08.22270616
4099  - http://medrxiv.org/content/early/2022/02/09/2022.02.08.22270616.short
4100  - http://medrxiv.org/content/early/2022/02/09/2022.02.08.22270616.full
AB  - Introduction To examine the associations between physical behaviours and type 2 diabetes mellitus (T2DM) risk in middle-aged South African men and women.Research design and methods This cross-sectional study included middle-aged men (n=403; age: median [IQR], 53.0 [47.8–58.8] years) and women (n=324; 53.4 [49.1–58.1] years) from Soweto, South Africa. Total movement volume (average movement in milli-g) and time (minutes/day) spent in different physical behaviours, including awake sitting/lying, standing, light intensity physical activity (LPA) and moderate-to-vigorous intensity physical activity (MVPA), were determined by combining the signals from two triaxial accelerometers worn simultaneously on the hip and thigh. All participants completed an oral glucose tolerance test, from which indicators of diabetes risk were derived. Associations between physical behaviours and T2DM risk were adjusted for sociodemographic factors and body composition.Results Total movement volume was inversely associated with measures of fasting and 2-h glucose and directly associated with insulin sensitivity, basal insulin clearance, beta-cell function, but these associations were not independent of fat mass, except for basal insulin clearance in women. In men, replacing 30 minutes of sitting/lying, standing or LPA with the same amount of MVPA time was associated with 1.2–1.4 mmol/L lower fasting glucose and 12.3–13.4 mgl2/mUmin higher insulin sensitivity. In women, substituting sitting/lying with the same amount of standing time or LPA was associated with 0.5–0.8 mmol/L lower fasting glucose. Substituting 30 minutes sitting/lying with the same amount of standing time was also associated with 3.2 mgl2/mUmin higher insulin sensitivity, and substituting 30 minutes of sitting/lying, standing or LPA with the same amount of MVPA time was associated with 0.25-0.29 ng/mIU higher basal insulin clearance in women.Conclusion MVPA is important in reducing T2DM risk in men and women but LPA appears to be important in women only. Recommendations for PA may differ by sex.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study received funding from the South African Medical Research Council, with funds received from the South African National Department of Health, the Research Councils UK Newton Fund to the University of Cambridge, GSK (Grant no: ES/N013891/1) and the South African National Research Foundation to the University of Witwatersrand. The work of KW, AS and SB were supported by the NIHR Cambridge Biomedical Research Centre and the Medical Research Council. TC is the recipient of a Wellcome Trust International Training Fellow grantAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Human Research Ethics Committee (HREC) Medical (M160604 and M160975) of the University of the Witwatersrand, Johannesburg, South AfricaI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors